Biomarkers of immunomodulatory effects in humans treated with antiCD200 antibodies

Details for Australian Patent Application No. 2011203879 (hide)

Owner Alexion Pharmaceuticals, Inc.

Inventors Faas McNight, Susan; Cofiell, Roxanne; Yan, Yan

Agent Shelston IP

Pub. Number AU-A-2011203879

PCT Pub. Number WO2011/085343

Priority 61/401,442 12.08.10 US; 61/294,066 11.01.10 US; 61/416,974 24.11.10 US; 61/337,997 11.02.10 US

Filing date 11 January 2011

Wipo publication date 14 July 2011

International Classifications

C07K 16/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

2 August 2012 PCT application entered the National Phase

  PCT publication WO2011/085343 Priority application(s): WO2011/085343

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011203884-Explicit congestion notification based rate adaptation using binary marking in communication systems

2011203867-Methods of providing weight loss therapy in patients with major depression